Karen S. King
- Genetics top 2%
- Genetic Associations and Epidemiology 5
- Chronic Lymphocytic Leukemia Research 4
- Forensic and Genetic Research 2
- Genetic diversity and population structure 2
- Pharmacology top 2%
- Hepatology top 10%
- Archeology top 5%
- Toxicology top 10%
-
- Colorectal Cancer Treatments and Studies 2
-
- Chronic Myeloid Leukemia Treatments 2
-
- Melanoma and MAPK Pathways 2
-
- Cancer Genomics and Diagnostics 2
- Co-authors
- Matthew R. NelsonCarlos D. BustamanteKatarzyna BrycAmit IndapJohn NovembreAdam R. BoykoAdam AutonToby Johnson
- Cited by
- GeneticsPharmacologyHepatology
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
Karen S. King
16 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Genetics 846
- Pharmacology 187
- Hepatology 56
- Archeology 67
- Toxicology 22
Countries citing papers authored by Karen S. King
This map shows the geographic impact of Karen S. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen S. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen S. King more than expected).
Fields of papers citing papers by Karen S. King
This network shows the impact of papers produced by Karen S. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen S. King. The network helps show where Karen S. King may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karen S. King, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2021 | 32 | |
| 3 | 2020 | 7 | |
| 4 | 2017 | 15 | |
| 5 | 2016 | 7 | |
| 6 | 2015 | 70 | |
| 7 | 2015 | 45 | |
| 8 | 2015 | 4 | |
| 9 | 2015 | 1 | |
| 10 | 2014 | 8 | |
| 11 | 2014 | 1 | |
| 12 | 2011 | 199 | |
| 13 | 2011 | 1 | |
| 14 | 2009 | 119 | |
| 15 | Genes mirror geography within Europebreakdown → | 2008 | 887 |
| 16 | 2008 | 34 | |
| 17 | 2007 | 78 |
About Karen S. King
Karen S. King is a scholar working on Genetics, Pharmacology and Genetics, having authored 17 papers that have together received 1.5k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Colorectal Cancer Treatments and Studies (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Forensic and Genetic Research (2 papers), Melanoma and MAPK Pathways (2 papers), Genetic diversity and population structure (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Genetics (846 citations), Pharmacology (187 citations) and Hepatology (56 citations). Karen S. King has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Matthew R. Nelson, Carlos D. Bustamante, Katarzyna Bryc, Amit Indap, John Novembre, Adam R. Boyko, Adam Auton, Toby Johnson, Sven Bergmann and Matthew Stephens. Their work appears in journals such as Nature, Nucleic Acids Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.